Abnormal low expression of SFTPC promotes the proliferation of lung adenocarcinoma by enhancing PI3K/AKT/mTOR signaling transduction

Baile Zuo; Lin Wang; Xiaoyan Li; Xin Li; Jinping Wang; Yanlu Xiong; Jie Lei; Xi Zhang; Yifan Chen; Qiongwen Liu; Jinke Jiao; Mengru Sui; Jinhan Fan; Ningxue Wu; Zewen Song; Guoyin Li

doi:doi:10.18632/aging.205191

← Back

Research Paper Volume 15, Issue 21 pp 12451—12475

Abnormal low expression of SFTPC promotes the proliferation of lung adenocarcinoma by enhancing PI3K/AKT/mTOR signaling transduction

Figure 12. SFTPC can inhibit PI3K/AKT/mTOR signal transduction. (A–C) A549 cells overexpressing or knocking down SFTPC were subjected to Western blot (A, B) and immunofluorescence (C) assay. (D–F) A549 cells were subjected to Western blot (D, E) and immunofluorescence (F) assays while overexpressing or knocking down SFTPC.